The role of inflammation and cytokines in brain injury

Neuroscience and Biobehavioral Reviews

Volumn 20, Issue 3, 1996, Pages 445-452

  Arvin, Babak ^a   Neville, Lewis F ^b   Barone, Frank C ^a   Feuerstein, Giora Z ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Adhesion molecules; Cytokine; Immune cells; Interleukine; Leukocyte; Neurotrauma; Stroke

Indexed keywords

CYTOKINE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; BRAIN INJURY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LEUKOCYTE ADHERENCE; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STROKE;

EID: 0029809417     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/0149-7634(95)00026-7     Document Type: Article

References (121)

1. Achim C.L., Heyes M.P., Wiley C.A. Quantitation of human immunodeficiency virus, immune activation factor and quinolinic acid in AIDS brains. J. Clin. Invest. 91:1985;2769-2775.
2. Aguayo A.J., Davies S., Bray G.M. Influences of glial environment on the elongation of axons after injury: transplantation studies in adult rodents. J. Exp. Biol. 95:1981;231-240.
3. Akira S., Taga T., Kishimoto T. Interleukin-6 in biology and medicine. Adv. Immunol. 54:1993;1-78.
4. Akira S., Hirano T., Taga T., Kishimoto T. Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF). FASEB J. 4:1990;2860-2867.
5. Alvarez X.A., Franco A., Fernandez-Novoa L., Cacabelos R. Effect of neurotoxic lesion in histaminergic neurons on brain tumor necrosis factor levels. Agents Actions. 41:1994;C70-C72.
6. Balasingam V.T., Tejada-Berges E., Wright R., Bouckova R., Yong V.W. Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J. Neurosci. 14:1994;846-856.
7. Ban E., Haour F., Lenstra R. Brain interleukin-1 expression induced by peripheral lipopolysaccharide administration. Cytokine. 4:1992;48-54.
8. Barone F.C.et al. Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histologic verification. J. Neurosci. Res. 29:1991;336-345.
9. 4 receptor binding in the rat focal ischemia. Stroke. 23:1992;1337-1348.
10. Barone F.C.et al. Time-related changes in myeloperoxidase activity and leukotriene B4 receptor binding reflect leukocyte influx in cerebral focal stroke. Molec. Chem. Neuropathol. 24:1995;13-80.
11. Bauer J.et al. Interleukin-6 and α-2-macroglobulin indicate an acute phase state in Alzheimer's disease cortices. FEBS Lett. 285:1992;111-114.
12. Bauer J.et al. The participation of Interleukin-6 in the pathogenesis of Alzheimer's disease. Res. Immunol. 143:1992;650-657.
13. Beerhuizen H., van Furth R. Monocyte adherence to human vascular endothelium. J. Leukocyte. Biol. 54:1993;363-378.
14. Berkenbosch F., Biewenga J., Brouns M., Rozemuller J.M., Strijbos P., van Damme Cytokines and inflammatory protein in Alzheimer's disease. Res. Immunol. 143:1992;657-663.
15. Bowes M.P., Ziviin J.A., Rothlein R. Monoclonal antibody to ICAM-1 adhesion site reduced neurological damage in a rabbit cerebral embolism stroke model. Exp. Neurol. 119:1993;215-219.
16. Brosnan C.F., Selmaj K., Ranie C.S. Hypothesis: a role for tumor necrosis factor in immune mediated demyelination and its relevance to multiple sclerosis. J. Neuroimmunol. 18:1988;87-94.
17. Chen H., Chopp M., Bodzin G. Neutropenia reduces the volume of cerebral infarct after transient middle cerebral artery occlusion in the rat. Neurosci. Res. Commun. 11:1988;93-99.
18. Chen H., Chopp M., Zhang R.L., Bodzin G., Chen Q., Rusche R.J., Todd R.F. III Anti-CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat. Ann. Neurol. 35:1994;458-463.
19. Cheng B., Christakos S., Mattson M.P. Tumor necrosis factor protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron. 12:1994;139-153.
20. Chopp M., Zhang R.L., Chen H., Li Y., Jiang N., Rusche J.R. Post ischemic administration of an anti-MAC-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat. Stroke. 25:1994;869-876.
21. Clark R.K.et al. Development of tissue damage, inflammation and resolution following stroke: an immunohistochemical and quantitative planimetric study. Brain Res. Bull. 31:1993;565-572.
22. Clark R.K., Lee E.V., White R.F., Jonak Z.L., Feuerstein G.Z., Barone F.C. Reperfusion following focal stroke hastens inflammation and resolution of ischemic injury. Brain Res. Bull. 35:1994;387-391.
23. Clark W.M., Madden K., Rothlein R., Zivin R.A. Reduction of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion molecule. J. Neurosurg. 75:1991;623-627.
24. de Kossodo S., Grau G.E. Role of cytokines and adhesion molecules in malaria immunopathology. Stem Cell Dayt. 11:1993;41-48.
25. Dereski M.O., Chopp M., Knight R.A., Chen H., Garcia J.H. Focal cerebral ischemia in the rat: temporal profile of neutrophil responses. Neurosci. Res. Comm. 11:1992;179-186.
26. Dickson D.W., Lee S.C., Mattiace L.A., Yen S.C., Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia. 7:1993;75-83.
27. Dinarello C.A. Biology of interleukin-1. FASEB J. 2:1988;108-115.
28. Dutka A.J., Kochanek P.M., Hallenbeck J.M. Influence of granulocytopenia on canine cerebral ischemia induced by an embolism. Stroke. 20:1989;390-395.
29. Eikelenboom P., Hack C.E., Rozemuller J.M., Stam F.C. Complement activation in amyloid plaques in Alzheimer's dementia. Virchows Archiv B. 56:1989;259-262.
30. Eikelenboom, P.; Rozemuller, J.M.; Fraser, H.; Berkenbosch, F.; Kamphorst, W.; Stam, F.C. Neuroimmunological mechanisms in cerebral amyloid deposition in Alzheimer's disease. In: Ishii, T.; Sekoe, D.; Allsop, D., eds. Frontiers of Science. Amsterdam: Elsevier Science; 1991:259-271.
31. Eng, L.F. Regulation of glial intermediate filaments in astrogliosis. In: Norenberg, M. D.; Hertz, L.; Schousboe, A., eds. Biochemical Pathology of Astrocytes. A. R. Liss, NY; 1990:79-90.
32. Feuerstein, G.Z.; Hunter, J.; Barone, F.C. Calcium channel blockers and neuroprotection. In: Lal, H.; Marango, P. J., eds. Emerging Strategies in Neuroprotection. Massachusetts: Birkhauser Boston; 1992:129-150.
33. Fillit H., Ding W., Buee L., Kalman J., Altstiel L., Lawlor B., Wolf-Klein G. Elevated circulating tumor necrosis factor levels in Alzheimer's disease. Neurosci. Lett. 131:1991;318-320.
34. Fontana A. On the cellular source and function of interleukin-6 produced in the central nervous system in viral diseases. Eur. J. Immunol. 19:1989;689-694.
35. Gadient R.A., Cron K.C., Otten U. Interleukin-1 beta and tumor necrosis factor-alpha synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytes. Neurosci. Lett. 117:1990;335-340.
36. Gatti S., Bartai T. Induction of tumor necrosis factor-alpha mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin-6. Brain Res. 624:1993;291-294.
37. Georgsson G., Gisladottir E., Arnadottir S. Quantitative assessment of the astrocytic response in natural scrapie of sheep. J. Comp. Pathol. 108:1993;229-240.
38. Giulian D., Woodward J., Young D.G., Krebs J.F., Lachman L.B. Interleukin-1 injection into mammalian brain stimulates astrogliosis and neovascularization. J. Neurosci. 8:1988;2485-2490.
39. Giulian D., Baker T.J., Shih L.N., Lachman L.B. Interleukin-1 of the central nervous system is produced by ameboid microglia. J. Exp. Med. 164:1986;594-604.
40. Giulian D., Chen J., Ingeman J.E., George J.K., Noponen M. The role of mononuclear phagocytes in wound healing after traumatic injury to the adult mammalian brain. J. Neurosci. 9:1989;4416-4429.
41. Gluckman P.et al. A role of IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem. Biophys. Res. Commun. 182:1992;593-599.
42. Goodman J.C., Robertson C.S., Grossman R.G., Narayan R.K. Elevation of tumor necrosis factor in head injury. J. Neuroimmunol. 30:1990;2-3.
43. Gorospe M., Kumar S., Baglioni C. Tumor necrosis factor increases stability of Interleukin-1 mRNA by activating protein kinase. C. J. Biol. Chem. 268:1993;6214-6220.
44. Granger D.N., Kvietys P.R. Leukocyte-endothelial cell adhesion induced by ischemia and reperfusion. Can. J. Physiol. Pharmacol. 71:1993;67-75.
45. Grau G.E., Pointaire P., Piguet P.F., Vesin C., Rosen H. Late administration of monoclonal antibody of leukocyte function-antigen 1 abrogates incipient murine cerebral malaria. Eur. J. Immunol. 21:1991;2265-2267.
46. Griffin W.S., Stanley L.C., Ling C., White L., Mac-Leod V., Perrot L.J., White C.L., Araoz C. Brain interleukin-1 and s-100 immunoreactivity are elevated in Down syndrome and Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 86:1989;7611-7615.
47. Griffin W.S., Sheng J.G., Gentleman S.M., Graham D.I., Mark R.E., Roberts G.W. Microglial interleukin-1α expression in human head injury: correlation with neuronal and neuritic β-amyloid precursor protein expression. Neurosci. Lett. 176:1994;133-136.
48. Grimaldi L.M.E., Martino G.V., Franciotta D.M., Brustia R., Costagno A., Pristera R., Lazzarin A. Elevated tumor necrosis factor-alpha levels in spinal fluid from HIV-1 infected patients with central nervous system involvement. Ann. Neurol. 29:1991;21-25.
49. Grogaard B., Shurer L., Gerdin B., Arfors K.E. Delayed hypoperfusion after incomplete forebrain ischemia in the rat. The role of polymorphonuclear leukocytes. J. Cereb. Blood Flow Metab. 9:1989;500-505.
50. Hallenbeck J.M., Dutka A.J., Tanishima T., Kochanek P.M., Kummaroo K.K., Thompson C.B., Obrenovitch T.P., Contrersa T.J. Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period. Stroke. 17:1986;246-253.
51. Hefti F., Hartikka J., Knusel B. Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases. Neurobiol. Aging. 10:1989;515-523.
52. Heinel L.A., Rubin S., Rosenwasser R.H., Vasthare U.S., Tuma R.F. Leukocyte involvement in cerebral infarct generation after ischemia and reperfusion. Brain Res. Bull. 34:1994;137-141.
53. Higgins G.A., Olschowka J.A. Induction of interleukin-1β mRNA in adult rat brain. Mol. Brain. Res. 9:1991;143-148.
54. Hofman F.M., Hinton D.R., Johnson K., Merrill J.E. Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 170:1989;607-612.
55. Ironside J.W., McCardle L., Rayward P.A., Bell J.E. Ubiquitin immunocytochemistry in human spongiform encephalopathies. Neuropathol. Appl. Neurobiol. 19:1993;134-140.
56. Kassis S., Prabhakar U. Inhibition of interleukin-1 (IL-1) and tumor necrosis factor (TNF) production by pyridinyl imidazole compounds is independent of cAMP elevating mechanisms. Agents & Actions. 39:1993;C64-C66.
57. Kobayashi E., Nakano H., Morimoto M., Tamaoki T. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific of protein kinase C. Biochem. Biophys. Res. Commun. 172:1990;993-999.
58. Kochanek P.M., Hallenbeck J.M. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke. 23:1992;1367-1379.
59. Leist T.P., Frei K., Kam-Hansen S., Zinkernagel R.M., Fontana A. Tumor necrosis factor α in cerebrospinal fluid during bacterial, but not viral, meningitis: evaluation in murine model infections and in patients. J. Exp. Med. 167:1988;1743-1748.
60. Lieberman A.P., Pitha P.M., Shin H.S., Shin M.L. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc. Natl. Acad. Sci. USA. 86:1989;6348-6352.
61. Lieberman A.P., Pitha P.M., Shin M.L. Poly(A) removal is the kinase regulated step in tumor necrosis factor mRNA decay. J. Biol. Chem. 267:1992;2123-2126.
62. Lieberman A.P., Pitha P.M., Shin M.L. Protein kinase C regulates TNFα mRNA stability in virus-stimulated astrocytes. J. Exp. Med. 172:1990;989-992.
63. Lindsay, R.M. Reactive gliosis. In: Fedoroff, S.; Vernadakis, A. eds. Astrocytes: Cell Biology and Pathology of Astrocytes, Vol. 3. Orlando, FL: Academic Press; 1986: 231-262.
64. Liu T., Young P.R., McDonnell P.C., White R.F., Barone F.C., Feuerstein G.Z. Cytokine-induced neutrophil chemoattractant mRNA expressed in cerebral ischemia. Neurosci. Lett. 164:1993;125-128.
65. Liu T., Clark R.K., McDonnell P.C., Young P.R., White R.F., Barone F.C., Feuerstein G.Z. Tumor necrosis factor-α expression in ischemic neurons. Stroke. 25:1994;1481-1488.
66. Liu T., McDonnell P.C., Young P.R., White R.F., Barone F.C., Feuerstein G.Z. Interleukin-1β mRNA expression in ischemic rat cortex. Stroke. 24:1993;1746-1751.
67. Mathiesen T., Andersson B., Loftenus A., von Holst H. Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage. J. Neurosurg. 78:1993;562-567.
68. Mattson M.P., Zhang Y., Bose S. Growth factors prevent mitochondrial dysfunction, loss of calcium homeostasis and cell injury, but not ATP depletion in hippocampal neurons deprived of glucose. Exp. Neurol. 121:1993;1-13.
69. McClain C., Cohen D., Philips R., Ott L., Young B. Increased plasma and ventricular fluid interleukin-6 levels in patients with head injury. J. Lab. Clin. Med. 118:1991;225-231.
70. Meldrum B. Protection against ischemic neuronal damage by drugs using an excitatory neurotransmission. Cerebrovasc. Brain Metab. Rev. 2:1990;27-57.
71. Merrill J.E., Chen I.S.Y. HIV-1 macrophages, glial cells and cytokines in AIDS nervous system brain. J. Exp. Med. 5:1991;2391-2397.
72. Minami M., Kuraishi Y., Satoh M. Effects of kainic acid on messenger RNA level of IL-1β, IL-6, TNFα and LIF in the rat brain. Biochem. Biophys. Res. Commun. 176:1991;593-598.
73. Minami M., Kuraishi Y., Yabuuchi K., Yamazaki A., Satoh M. Induction of interleukin-1β mRNA in rat brain after transient forebrain ischemia. J. Neurochem. 58:1991;390-392.
74. Mogi M., Harada M., Riederer P., Narabayashi H., Fujita K., Nagatsu T. Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from Parkinsonian patients. Neurosci. Lett. 165:1994;208-210.
75. Mori E.M., del Zoppo G.L., Chambers J.D., Copeland B.J., Arfors K.E. Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons. Stroke. 23:1992;712-718.
76. Norton W.T., Aquino D.A., Hozumi I., Chiu T.C., Brosnan C.F. Quantitative aspects of reactive gliosis: a review. Neurochem. Res. 17:1992;877-885.
77. Nozaki K., Finklestein S.P., Bealm M.F. Basic fibroblast growth factor protects against hypoxia-ischemia and MMDA neurotoxicity in neonatal rats. J. Cereb. Blood Flow Metab. 13:1993;221-228.
78. O'Callaghan J.P. Quantitative features of reactive gliosis following toxicant-induced damage of the CNS. Ann. N.Y. Acad. Sci. 679:1991;195-209.
79. Okada Y., Copeland B.R., Mori E., Tung M.M., Thomas W.S., del Zoppa G.S. P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion. Stroke. 25:1994;202-211.
80. Perry V.H., Gordon S. Macrophages and the nervous system. Int. Rev. Cytol. 125:1991;203-244.
81. Pober J.S., Cotran R.S. Cytokines and endothelial cell biology. Physiol. Rev. 70:1990;427-451.
82. Porta J., Carota A., Pizzolato G.P., Wildi E., Widmer M.C., Margairaz C., Grau G.E. Immunopathological changes in human cerebral malaria. Clin. Neuropathol. 12:1993;142-146.
83. Pozzilliet al. Imaging of leukocytic infiltration in human cerebral infarcts. Stroke. 16:1985;251-255.
84. Prabhakar U., Lipshutz D., Pullen M., Turchin H., Kassis S., Nambi P. Protein kinase C regulates TNF-alpha production by human monocytes. Eur. Cytokine Network. 4:1993;31-37.
85. Reier, P.J. Gliosis following CNS injury: the anatomy of astrocytic scars and their influences of axonal elongation. In: Fedoroff, S.; Vernadakis, A., eds. Astrocytes: Cell Biology and Pathology of Astrocytes. Orlando, FL: Academic Press; 1986:263-324.
86. Rothwell N.J., Ruton J.K. Involvement of interleukin-1 and lipocortin-1 in ischemic brain damage. Cereb. and Brain Metab. Rev. 5:1993;178-198.
87. Rothwell N.J. Functions and mechanism of interleukin-1 in the brain. TIPS. 12:1991;430-435.
88. Rott O., Tontsch U., Fleischer B., Cash E. Interleukin-6 production in "normal" and HTLV-1 tax-expressing brain-specific endothelial cells. Eur. J. Immunol. 23:1993;1987-1991.
89. Rozemuller J.M., Eikelenboom P., Pals S.T., Stam F.C. Microglial cells around amyloid plaques in Alzheimer's disease express leucocyte adhesion molecules of the LFA 1 family. Neurosci. Lett. 101:1989;288-292.
90. Sasseville V.G., Newman W.A., Lackner A.A., Smith M.D., Lausen N.C. Elevated vascular cell adhesion molecule-1 in AIDS encephalitis induced by simian immunodeficiency virus. Am. J. Pathol. 141:1992;1021-1030.
91. Sawada M., Kondo N., Suzumura A., Marunouchi T. Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res. 491:1989;394-397.
92. Schobitz B., de Kolet E.R., Sutanto W., Holsboer F. Cellular localization of interleukin-6 mRNA and interleukin-6 receptor mRNA in rat brain. Eur. J. Neurosci. 5:1993;1426-1435.
93. Selmaj K.W., Farooq M., Norton W.T., Raine C.S., Brosnan C.F. Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. J. Immunol. 144:1990;29-135.
94. Semmler J.H., Wachtel H., Endres S. The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-α production by human mononuclear cells. Int. J. Immunopharm. 15:1993;409-413.
95. Sharief M.K., Noori M.A., Ciardi M., Cirilli A., Thompson E.J. Increase levels of circulation ICAM-1 in serum and cerebrospinal fluid in patients with active multiple sclerosis. Correlation with TNFα and blood brain barrier damage. J. Immunol. 43:1993;15-21.
96. Shiga Y., Onnodera H., Kogure K., Yamasaki Y., Yashima Y., Syozuhara H., Sendo F. Neutrophil as a mediator of ischemic edema formation in the brain. Neurosci. Lett. 125:1991;110-112.
97. Shigeno T., Mima T., Takakura K., Graham D.I., Kato G., Hashimoto Y., Furukawa S. Amelioration of delayed neuronal death in hippocampus by nerve growth factor. J. Neurosci. 11:1991;2914-2919.
98. Shohami E., Novikov M., Bass R., Yamin A., Gallily R. Closed head injury triggers early production of TNFα and IL-6 by brain tissue. J. Cereb. Blood Flow Metab. 14:1994;615-619.
99. Siren A.L.et al. Release of proinflammatory and prothrombotic mediators in the brain and peripheral circulation in spontaneously hypertensive and normotensive Wistar-Kyoto rats. Stroke. 23:1992;1643-1651.
100. Smith R.A., Baglioni C. Characterization of TNF receptors. Immunol. Ser. 56:1992;149-160.
101. Takao T., Tracey D.E., Mitchel W.M., De Souza E.B. Interleukin-1 receptors in mouse brain: characterization and neuronal localization. Endocrinology. 127:1990;3070-3078.
102. Taupin V., Toulmond S., Serrano A., Benavides J., Zavala F. Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. J. Neuroimmunol. 42:1993;177-186.
103. Tchelingerian J.L., Quinonero J., Booss J., Jacque C. Localization of TNFα and IL-1α immunoactivities in striatal neurons after surgical injury to hippocampus. Neuron. 10:1993;213-224.
104. Toulmond T.V., Serrano A., Benavides J., Zavala F. Increase in IL-6 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro54866, a peripheral-type (p site) ligand. J. Neuroimmunol. 42:1993;177-185.
105. Tracey K.J., Cerami A. Tumor necrosis factor, other cytokines and disease. Ann. Rev. Cell Biol. 9:1993;317-3432.
106. Tschaikowsky K., Brain J.D. Staurosporine encapsulated into pH-sensitive liposomes reduces TNF production and increases survival in rat endotoxin shock. Shock. 1:1994;401-407.
107. Tsuchihashi Y., Kitamura T., Fujita S. Immunofluorescence studies of the monocytes in the injured rat brain. Acta Neuropathol. (Berl). 53:1981;213-219.
108. Vasthare U.S., Heinel L.A., Rosenwasser R.H., Turner R.F. Leukocyte involvement in cerebral ischemia and reperfusion injury. Surg. Neurol. 33:1990;261-265.
109. Waage A., Holstensen A., Shalaby R., Brandtzaeg P., Kierulf P., Espevick T. Local production of tumor necrosis factor α, interleukin-1 and interleukin-6 in meningococcal meningitis: relation to the inflammatory response. J. Exp. Med. 170:1989;1859-1867.
110. Wang X.K., Yue T.L., Barone F.C., Feuerstein G.Z. Concomitant cortical expression of TNFα and IL-1β mRNA following transient focal ischemia. Mol. Chem. Neuropathol. 23:1994;103-114.
111. Wang, X.K.; Siren, A.L.; Yue, T.L.; Barone, F.C.; Feuerstein, G.Z. Upregulation of intracellular adhesion molecule-1 (ICAM-1) on brain microvascular endothelial cells in rat ischemic cortex. Mol. Brain Res. (in press).
112. Wang X.K., Yue T.L., Barone F.C., Feuerstein G.Z. Demonstration of increased endothelial-leukocyte adhesion molecule 1 mRNA expression in rat ischemic cortex. Stroke. 26:1995;1665-1669.
113. Wilkinson S.E., Hallam T.J. Protein kinase C: is its pivotal role in cellular activation over-stated? TIPS. 15:1994;53-57.
114. Williams A.E., Van Damme A., Man A., Hing W.K.H., Berkenbosch F., Eikelenboom P., Fraser H. Cytokines, prostaglandins and lipocortin-1 are present in the brains of scrapie-infected mice. Brain Res. 654:1994;200-206.
115. Williams A.E., Lawson L., Perry V.H., Fraser H. Characterization of the microglial response in murine scrapie. Neuropathol. Appl. Neurobiol. 20:1994;47-55.
116. Woodroofe M.N., Sarna G.S., Wadhwa M., Hayes G.M., Loughlin A.J., Tinker A., Cuzner M.L. Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo macrodialysis: evidence of a role for microglia in cytokine production. J. Neuroimmunol. 33:1991;227-236.
117. Yan H.Q., Banos M.A., Herregodts P., Hooghe R., Hooghe-Peters E.L. Expression of interleukin (IL)-1β, IL-6 and their respective receptors in the normal rat brain and after injury. Eur. J. Immunol. 22:1991;2963-2971.
118. Yoshimura T., Robinson E.A., Tanaka S., Appella E., Kuratsu J.I., Leonard E.J. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J. Exp. Med. 169:1989;1449-1459.
119. Young P.R., McDonnell P., Dunnington D., Hand A., Laydon J., Lee J. Pyridinyl imidazoles inhibit IL-1 and TNF production at the protein level. Agents & Actions. 39:1993;C67-C69.
120. Zhang, R. et al. Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat. Neurology (in press).
121. Zhang Y., Tatsuno T., Carney J.M., Mattson M.P. Basic FGF, NGF, and IGFs protect hippocampal and cortical neurons against iron-induced degeneration. J. Cereb. Blood Flow Metab. 13:1993;378-388.